David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CareTrust REIT
CTRE
$9.37B
| $24.8M | 0.02% |
1,064,986
-280,835
| -21% | -$6.45M |
|
752
Rambus
RMBS
$9.44B
| $24.8M | 0.02% |
1,273,952
-361,903
| -22% | -$7.27M |
|
753
PUT
Biogen
BIIB
$32.2B
| $24.7M | 0.02% |
88,400
-41,800
| -32% | -$11.3M |
|
|
SIX
754
DELISTED
Six Flags Entertainment Corp.
SIX
| $24.7M | 0.02% |
+531,543
| New | +$22.2M |
|
755
Conduent
CNDT
$250M
| $24.6M | 0.02% |
3,699,320
-1,381,911
| -27% | -$7.88M |
|
756
Nomad Foods
NOMD
$1.69B
| $24.6M | 0.02% |
896,772
-176,598
| -16% | -$4.57M |
|
757
Cognex
CGNX
$9.85B
| $24.6M | 0.02% |
296,690
+99,238
| +50% | +$8.27M |
|
|
NSTG
758
DELISTED
NanoString Technologies, Inc.
NSTG
| $24.6M | 0.02% |
374,178
-70,078
| -16% | -$4.92M |
|
759
Zai Lab
ZLAB
$2.88B
| $24.6M | 0.02% |
184,232
-42,282
| -19% | -$6.55M |
|
760
Cummins
CMI
$78.7B
| $24.5M | 0.02% |
94,595
+15,837
| +20% | +$3.96M |
|
761
Commault Systems
CVLT
$5.43B
| $24.4M | 0.02% |
378,281
-238,941
| -39% | -$15.2M |
|
762
Upbound Group
UPBD
$1.12B
| $24.4M | 0.02% |
422,550
-158,222
| -27% | -$8.28M |
|
763
CALL
Chewy
CHWY
$10B
| $24.3M | 0.02% |
287,100
+90,600
| +46% | +$8.82M |
|
764
PUT
Marathon Petroleum
MPC
$102B
| $24.3M | 0.02% |
454,500
-250,000
| -35% | -$12.6M |
|
|
HIBB
765
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $24.3M | 0.02% |
352,418
-142,599
| -29% | -$8.79M |
|
|
TPTX
766
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $24.2M | 0.02% |
255,929
+161,628
| +171% | +$19.2M |
|
|
AL
767
DELISTED
Air Lease Corp
AL
| $24.1M | 0.02% |
492,472
+215,390
| +78% | +$9.82M |
|
768
Best Buy
BBY
$18.4B
| $24.1M | 0.02% |
209,698
-249,991
| -54% | -$28M |
|
769
General Motors
GM
$76.3B
| $24.1M | 0.02% |
418,848
+179,794
| +75% | +$9.55M |
|
770
Analog Devices
ADI
$181B
| $24M | 0.02% |
154,743
-72,348
| -32% | -$11.1M |
|
771
Corteva
CTVA
$55.3B
| $24M | 0.02% |
514,189
-189,122
| -27% | -$8.37M |
|
772
Globe Life
GL
$13.3B
| $23.7M | 0.02% |
245,542
+96,877
| +65% | +$9.28M |
|
|
IRBT
773
DELISTED
iRobot
IRBT
| $23.7M | 0.02% |
194,067
-215,256
| -53% | -$24.5M |
|
774
Textron
TXT
$14.1B
| $23.7M | 0.02% |
422,049
+236,183
| +127% | +$12M |
|
775
Curtiss-Wright
CW
$22.7B
| $23.6M | 0.02% |
199,262
-34,631
| -15% | -$4.01M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.